1. Ahima RS, Osei SY. Adipokines in obesity. Front Horm Res 2008; 36: 182–197.
2. Baldock PA, Allison S, McDonald MM et al. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 2006; 21: 1600–1607.
3. Bartell SM, Isales CM, Baile CA et al. CART deficiency increases body weight but does not alter bone strength. J Musculoskelet Neuronal Interact 2008; 8: 146–153.
4. Bjørbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004; 59: 305–331.
5. Bonnet N, Pierroz DD, Ferrari SL. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. J Musculoskelet Neuronal Interact 2008; 8: 94–104.
6. Bronský J, Kotaska K, Průša R. Ghrelin – structure, function and clinical applications. Česk Fyziol 2004; 53: 80–85.
7. Caetano-Lopes J, Canhão H, Fonseca JE. Osteoblasts and bone formation. Acta Rheumatol Port 2007; 32: 103–110.
8. Carrasco F, Ruz M, Rojas P et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg 2009; 19: 41–46.
9. Castellano JM, Roa J, Luque RM et al. KiISS-1/kisspeptins and the metabolic control of reproduction: physiologic roles and putative physiopathological implications. Peptides 2009; 30: 139–145.
10. Ealey KN, Kaludjerovic J, Archer MC et al. Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood) 2008; 233: 1546–1553.
11. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 2008; 473: 231–236.
12. Fairbrother UL, Tankó LB, Halley AJ et al. Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women. J Bone Miner Res 2007; 22: 544–550.
13. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI et al. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J)2007; 83 (Suppl 5): S192–S203.
14. Golden NH, Carlson JL. The pathophysiology of amenorrhea in the adolescent. Ann N Y Acad Sci 2008; 1135: 163–178.
15. Gonnelli S, Caffarelli C, Del Santo K et al. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 2008; 83: 55–60.
16. Hamrick MW, Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporosis Int 2008; 19: 905–912.
17. Holmen SL, Zylstra CR, Mukherjee A et al. Essential role of beta‑catenin in postnatal bone acquisition. J Biol Chem 2005; 280: 21162–21168.
18. Jéquier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002; 967: 379–388.
19. Jürimäe J, Jürimäe T, Leppik A et al. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 2008; 26: 618–623.
20. Kaplowitz PB. Link between body fat and timing of puberty. Pediatrics 2008; 121 (Suppl 3): S208–S217.
21. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin‑the classical, resistin‑the controversial, adiponectin‑the promissing, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525–546.
22. Koh JM, Kim DJ, Hong JS et al. Estrogen receptor alpha gene polymorphisms Pvu II and Xba I influence association between leptin receptor gene polymorphism (Gln223Arg) and bone mineral density in young men. Eur J Endocrinol 2002; 147: 777–783.
23. Kršek M, Rosická M, Haluzík M et al. The changes in serum ghrelin levels and their relationship to IGF‑I, its binding proteins and leptin in women patiens with anorexia nervosa. Vnitř Lék 2002; 48: 948–951.
24. Lac G, Cavalie H, Ebal E et al. Effects of a high fat diet on bone of growing rats. Correlations between visceral fat, adiponectin and bone mass density. Lipids Health Dis 2008; 7: 16.
25. Lerner UH, Persson E. Osteotropic effects by the neuropeptides calcitonin gene‑related peptide, substance P and vasoactive intestinal peptide. J Musculoskelet Neuronal Interact 2008; 8: 154–165.
26. Makovey J, Naganathan V, Seidel M et al. Gender differences in plasma ghrelin and its relations to body composition and bone – an opposite-sex twin study. Clin Endocrinol (Oxford) 2007; 66: 530–537.
27. Misra M, Miller KK, Kuo K et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005; 289: E347–E356.
28. Misra M, Miller KK, Cord J et al. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007; 92: 2046–2052.
29. Morelli A, Marini M, Mancina R et al. Sex steroids and leptin regulates the „first Kiss“ (KiSS 1/G-protein‑coupled receptor 54 system) in human gonadotropin‑releasing-hormone-secreting neuroblasts. J Sex Med 2008; 5: 1097–1113.
30. Matkovic V, Ilich J, Skugor M et al. Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 1997; 82: 3239–3245.
31. Oh KW, Lee WY, Rhee EJ et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005; 63: 131–138.
32. Peng XD, Xie H, Zhao Q et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008; 387: 31–35.
33. Pierroz DD, Bouxsein ML, Rizzoli R et al. Combined treatment with a beta‑blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Bone 2006; 39: 260–267.
34. Popovic V, Duntas LH. Leptin, TRH and ghrelin: influence on energy homeostasis at rest and during exercise. Horm Metab Res 2005; 37: 533–537.
35. Qui Y, Sun X, Qui X et al. Decreased circulating leptin levels and its association with body and bone mass in girls with adolescent idiopathic scoliosis. Spine 2007; 32: 2703–2710.
36. Richert L, Chevalley T, Manen D et al. Bone mass in prepubertal boys is associated with a Gln223Arg amino acid substitution in the leptin receptor. J Clin Endocrinol Metab 2007; 92: 4380–4386.
37. Scariano JK, Garry PJ, Montoya GD et al. Serum leptin levels, bone mineral density and osteoblast alkaline phosphatase activity in elderly men and women. Mech Ageing Dev 2003; 124: 281–286.
38. Schwartz AV, Sellmeyer DE, Vittinghoff E et al. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 2006; 91: 3349–3354.
39. Suzuki N, Somei M, Kitamura K et al. Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: implications for the treatment of bone diseases. J Pineal Res 2008; 44: 326–334.
40. Thomas T. The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol 2004; 4: 295–300.
41. Thommesen L, Stunes AK, Monjo M et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006; 99: 824–834.
42. Zoico E, Zamboni M, Di Francesco V et al. Relation between adiponectin and bone mineral density in elderly postmenopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J Endocrinol Invest 2008; 31: 297–302.
43. Žofková I. Hormonal aspects of the muscle-bone unit. Physiol Res 2008; 57 (Suppl 1): S159–S169.
44. Žofková I, Hill M. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women. Endocr Regul 2008; 42: 121–127.